Representation of Patients With Cardiovascular Disease in Pivotal Cancer Clinical Trials

被引：40

作者：

Bonsu, Janice ^{[1
]}

Charles, Lawrence ^{[1
]}

Guha, Avirup ^{[1
]}

Awan, Farrukh ^{[3
,4
]}

Woyach, Jennifer ^{[3
,4
]}

Yildiz, Vedat ^{[2
]}

Wei, Lai ^{[2
]}

Jneid, Hani ^{[5
]}

Addison, Daniel ^{[1
]}

机构：

[1] Ohio State Univ, Div Cardiol, Cardiooncol Program, Columbus, OH 43210 USA

[2] Ohio State Univ, Ctr Biostat, Dept Biomed Informat, Columbus, OH 43210 USA

[3] Ohio State Univ, James Canc Hosp, Div Hematol, Columbus, OH 43210 USA

[4] Ohio State Univ, Solove Res Inst, Columbus, OH 43210 USA

[5] Baylor Coll Med, Michael E DeBakey VA Med Ctr, Div Cardiol, Houston, TX 77030 USA

来源：

CIRCULATION | 2019年 / 139卷 / 22期

关键词：

cancer; cardiovascular disease; clinical trials as topic; underrepresentation; United States Food and Drug Administration;

D O I：

10.1161/CIRCULATIONAHA.118.039180

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2594 / 2596

页数：3

共 5 条

[1]

[Anonymous], DRUGS FDA

[2] Cancer patients with cardiovascular disease have survival rates comparable to cancer patients within the age-cohort of 10 years older without cardiovascular morbidity [J].

Janssen-Heijnen, Maryska L. G. ;

Szerencsi, Karolina ;

van de Schans, Saskia A. M. ;

Maas, Huub A. A. M. ;

Widdershoven, Jos W. ;

Coebergh, Jan Willem W. .

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2010, 76 (03) :196-207

[3] Cancer treatment and survivorship statistics, 2016 [J].

Miller, Kimberly D. ;

Siegel, Rebecca L. ;

Lin, Chun Chieh ;

Mariotto, Angela B. ;

Kramer, Joan L. ;

Rowland, Julia H. ;

Stein, Kevin D. ;

Alteri, Rick ;

Jemal, Ahmedin .

CA-A CANCER JOURNAL FOR CLINICIANS, 2016, 66 (04) :271-289

[4] Cardiovascular Toxic Effects of Targeted Cancer Therapies [J].

Moslehi, Javid J. .

NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (15) :1457-1467

[5]

Sheng Calvin Chen, 2016, JACC Basic Transl Sci, V1, P386, DOI 10.1016/j.jacbts.2016.05.008

← 1 →